Redsense Medical AB (publ) (XSAT:REDS)
Sweden · Delayed Price · Currency is SEK 3.930
-0.140 (-3.44%)
At close: Aug 6, 2026
Redsense Medical AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 29.12 | 26.8 | 32.63 | 25.56 | 17.79 | 16.9 | |
Revenue Growth | -16.37% | -17.85% | 27.66% | 43.66% | 5.26% | -1.46% |
Cost of Revenue | 10.21 | 11.24 | 10.69 | 12.36 | 5.49 | 5.95 |
Gross Profit | 18.92 | 15.56 | 21.93 | 13.2 | 12.3 | 10.96 |
Selling, General & Admin | 19.4 | 18.66 | 19.76 | 17.54 | 22.46 | 22.77 |
Depreciation & Amortization Expenses | 0.96 | 0.63 | 0.07 | 0.06 | 0.05 | 0.17 |
Other Operating Expenses | 1.69 | 3.65 | 1.89 | 0.63 | 0 | - |
Total Operating Expenses | 22.05 | 22.93 | 21.72 | 18.23 | 22.51 | 22.95 |
Operating Income | -3.13 | -7.37 | 0.21 | -5.04 | -10.21 | -11.99 |
Interest Income | - | - | 0.17 | 0.06 | 3.59 | 4.07 |
Interest Expense | - | - | -0.04 | -0.03 | -0.1 | -0.05 |
Other Non-Operating Income (Expense) | 1.55 | -6.98 | 0 | 1.02 | -2.04 | - |
Total Non-Operating Income (Expense) | 1.55 | -6.98 | 0.13 | 1.05 | 1.45 | 4.02 |
Pretax Income | -2.9 | -7.17 | 0.34 | -4.51 | -8.76 | -7.97 |
Net Income | -2.9 | -7.17 | 0.34 | -4.51 | -8.76 | -7.97 |
Net Income to Common | -2.9 | -7.17 | 0.34 | -4.51 | -8.76 | -7.97 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 2 | 16 | 17 | 14 | 14 | 14 |
Shares Outstanding (Diluted) | 2 | 16 | 17 | 14 | 14 | 14 |
Shares Change | 2171.93% | -4.68% | 21.25% | 0.44% | 0.39% | -0.39% |
EPS (Basic) | -1.36 | -0.44 | 0.02 | -0.32 | -0.62 | -0.57 |
EPS (Diluted) | -1.36 | -0.44 | 0.02 | -0.32 | -0.62 | -0.57 |
EPS Growth | - | - | - | - | - | - |
Free Cash Flow | -3.46 | -5.23 | -8.25 | -5.1 | -9.83 | -11.86 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -1.62 | -0.32 | -0.48 | -0.36 | -0.70 | -0.85 |
Gross Margin | 64.95% | 58.06% | 67.22% | 51.64% | 69.15% | 64.82% |
Operating Margin | -10.76% | -27.48% | 0.64% | -19.71% | -57.38% | -70.95% |
Profit Margin | -9.96% | -26.76% | 1.05% | -17.66% | -49.23% | -47.17% |
FCF Margin | -11.89% | -19.51% | -25.27% | -19.97% | -55.26% | -70.18% |
EBITDA | -3.13 | -7.37 | 0.21 | -5.04 | -10.21 | -11.99 |
EBIT | -3.13 | -7.37 | 0.21 | -5.04 | -10.21 | -11.99 |
EBIT Margin | -10.76% | -27.48% | 0.64% | -19.71% | -57.38% | -70.95% |